Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer (Q36729611)

From Wikidata

Jump to navigation Jump to search

scientific article published on 2 November 2015

Language	Label	Description	Also known as
English	Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer	scientific article published on 2 November 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

18

object named as

Rafael Rosell

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Erik Thunnissen

13

object named as

Erik Thunnissen

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Daniëlle A M Heideman

12

object named as

Danielle A M Heideman

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

R Jonas A Nilsson

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Niki Karachaliou

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jordi Berenguer

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ana Gimenez-Capitan

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Pepijn Schellen

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Cristina Teixido

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jihane Tannous

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Justine L Kuiper

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Esther Drees

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Magda Grabowska

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Marte van Keulen

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Anne-Marie C Dingemans

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Santiago Viteri

15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Bakhos A Tannous

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Ana Drozdowskyj

17

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Egbert F Smit

19

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Thomas Wurdinger

20

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

2 November 2015

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1066-1075

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

First-line crizotinib versus chemotherapy in ALK-positive lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Patient-derived models of acquired resistance can identify effective drug combinations for cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

ALK-dependent control of hypoxia-inducible factors mediates tumor growth and metastasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Platelets effects on tumor growth

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Platelets promote tumor growth and metastasis via direct interaction between Aggrus/podoplanin and CLEC-2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): a single-arm, open-label, phase 1-2 study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Mechanisms of acquired crizotinib resistance in ALK-rearranged lung Cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Circulating tumor cells: approaches to isolation and characterization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Transcription profiling in human platelets reveals LRRFIP1 as a novel protein regulating platelet function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Platelets actively sequester angiogenesis regulators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

30 September 2017

Blood platelets contain tumor-derived RNA biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

5 September 2018

DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4808052

5 September 2018

Ceritinib in ALK-rearranged non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26544515

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.18632/ONCOTARGET.6279

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36729611&oldid=2101398605"